Answers are grounded in this paper and cite their sources.
Transarterial chemoembolization (TACE) is a treatment modality in patients with hepatocellular carcinoma (HCC) at intermediate stage when resection or liver transplantation is not feasible. It is used as a palliative therapy or bridging therapy until the time of liver transplantation due to effective reduction in tumor size and delay in tumor progression ( Bruix & Sherman, 2011 ; Cabrera & Nelson, 2010 ; Graziadei et al., 2003 ). Several complications such as nausea, vomiting, and abdominal distention are frequently observed after TACE. However, major ACUTE NECROTIZING PANCREATITIS AFTER TRANSARTERIAL CHEMOEMBOLIZATION IN A PATIENT WITH HEPATOCELLULAR CANCER: CASE REPORT AND REVIEW OF THE LITERATURE
No takes yet. Share an insight, caveat, or question.
Öcal et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: